TC BioPharm (Holdings) PLC (TCBP)
1.44
-0.04
(-2.70%)
USD |
NASDAQ |
May 02, 14:00
TC BioPharm Market Cap: 4.601M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 01, 2024 | 4.729M |
| April 30, 2024 | 4.569M |
| April 29, 2024 | 4.761M |
| April 26, 2024 | 4.888M |
| April 25, 2024 | 5.016M |
| April 24, 2024 | 4.697M |
| April 23, 2024 | 5.048M |
| April 22, 2024 | 5.048M |
| April 19, 2024 | 4.726M |
| April 18, 2024 | 4.537M |
| April 17, 2024 | 4.313M |
| April 16, 2024 | 4.250M |
| April 15, 2024 | 4.186M |
| April 12, 2024 | 5.144M |
| April 11, 2024 | 5.528M |
| April 10, 2024 | 5.432M |
| April 09, 2024 | 5.943M |
| April 08, 2024 | 5.687M |
| April 05, 2024 | 6.071M |
| April 04, 2024 | 6.230M |
| April 03, 2024 | 4.154M |
| April 02, 2024 | 4.058M |
| April 01, 2024 | 4.058M |
| March 28, 2024 | 3.179M |
| March 27, 2024 | 3.470M |
| Date | Value |
|---|---|
| March 26, 2024 | 3.446M |
| March 25, 2024 | 3.494M |
| March 22, 2024 | 3.688M |
| March 21, 2024 | 3.931M |
| March 20, 2024 | 3.737M |
| March 19, 2024 | 3.543M |
| March 18, 2024 | 3.931M |
| March 15, 2024 | 4.076M |
| March 14, 2024 | 4.659M |
| March 13, 2024 | 4.125M |
| March 12, 2024 | 4.368M |
| March 11, 2024 | 4.149M |
| March 08, 2024 | 2.572M |
| March 07, 2024 | 2.524M |
| March 06, 2024 | 2.548M |
| March 05, 2024 | 3.057M |
| March 04, 2024 | 3.057M |
| March 01, 2024 | 3.227M |
| February 29, 2024 | 3.057M |
| February 28, 2024 | 3.264M |
| February 27, 2024 | 3.082M |
| February 26, 2024 | 2.936M |
| February 23, 2024 | 2.548M |
| February 22, 2024 | 2.960M |
| February 21, 2024 | 2.645M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
0.9102M
Minimum
Feb 05 2024
59.57M
Maximum
Feb 11 2022
9.946M
Average
4.682M
Median
Nov 21 2023
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 297.42M |
| Biodexa Pharmaceuticals Plc | 5.525M |
| NuCana PLC | 8.458M |
| Autolus Therapeutics PLC | 1.108B |
| Mereo BioPharma Group PLC | 443.96M |
Market Cap Related Metrics
| PS Ratio | 0.0967 |
| Price to Book Value | 1.345 |
| Price | 1.44 |
| Earnings Yield | -351.2% |